Stock Taper

ARKG

ARK Genomic Revolution ETF

ARKG

ARK Genomic Revolution ETF • ARK

$31.80 ▲ 4.09% (+1.25)

Managing Company ARK

Asset Under Management $1.25B

Inception Date Oct 30, 2014

Expense Ratio 0.75%

52w High $34.06

52w Low $17.50

Volume 3,840,564

Avg Volume 3,434,849

Asset Class Equity

About ARK Genomic Revolution ETF

ARKG is an actively managed ETF that seeks long-term growth of capital by investing in domestic and foreign equity securities of companies relevant to the genomics revolution.

Managing Company ARK

Asset Under Management $1.25B

Inception Date Oct 30, 2014

Expense Ratio 0.75%

52w High $34.06

52w Low $17.50

Volume 3,840,564

Avg Volume 3,434,849

Asset Class Equity

About ARK Genomic Revolution ETF

ARKG is an actively managed ETF that seeks long-term growth of capital by investing in domestic and foreign equity securities of companies relevant to the genomics revolution.

HOLDINGS (Top 20)

Stock	Name	Weight	Shares	Market Value
CRSP	CRISPR Therapeutics AG	8.85%	1.95M	$113.56M
TWST	Twist Bioscience Corporation	6.28%	2.18M	$80.51M
GH	Guardant Health, Inc.	5.71%	652.30K	$73.27M
TEM	Tempus AI, Inc.	5.59%	7.85M	$71.79M
BEAM	Beam Therapeutics Inc.	4.90%	2.22M	$62.89M
TXG	10x Genomics, Inc.	4.83%	3.21M	$61.91M
RXRX	Recursion Pharmaceuticals, Inc.	4.21%	11.88M	$54.04M
VCYT	Veracyte, Inc.	3.81%	1.07M	$48.95M
CDNA	CareDx, Inc	3.05%	2.08M	$39.10M
SDGR	Schrödinger, Inc.	3.03%	2.07M	$38.90M
ADPT	Adaptive Biotechnologies Corporation	2.64%	2.10M	$33.84M
NTLA	Intellia Therapeutics, Inc.	2.24%	2.95M	$28.74M
NRIX	Nurix Therapeutics, Inc.	2.11%	1.56M	$27.12M
WGS	GeneDx Holdings Corp.	1.92%	181.11K	$24.60M
PACB	Pacific Biosciences of California, Inc.	1.77%	10.91M	$22.70M
PRME	Prime Medicine, Inc.	1.41%	4.87M	$18.03M
ARCT	Arcturus Therapeutics Holdings Inc.	1.32%	2.55M	$16.89M
CMPS	COMPASS Pathways plc	1.15%	2.10M	$14.78M
INCY	Incyte Corporation	1.10%	132.91K	$14.18M
VRTX	Vertex Pharmaceuticals Incorporated	0.93%	25.36K	$11.88M

SECTOR HOLDINGS

Healthcare

Healthcare

100.00%

ASSET ALLOCATION BY REGION

United States

89.87%

Switzerland

8.67%

United Kingdom

1.23%

Other

0.23%

SECTOR HOLDINGS

Healthcare

Healthcare

100.00%

ASSET ALLOCATION BY REGION

United States

89.87%

Switzerland

8.67%

United Kingdom

1.23%

Other

0.23%

Holdings (Top 20)

CRSP

CRSP

CRISPR Therapeutics AG

Weight: 8.85% Shares: 1.95M Value: $113.56M

TWST

TWST

Twist Bioscience Corporation

Weight: 6.28% Shares: 2.18M Value: $80.51M

GH

Guardant Health, Inc.

Weight: 5.71% Shares: 652.30K Value: $73.27M

TEM

TEM

Tempus AI, Inc.

Weight: 5.59% Shares: 7.85M Value: $71.79M

BEAM

BEAM

Beam Therapeutics Inc.

Weight: 4.90% Shares: 2.22M Value: $62.89M

TXG

TXG

10x Genomics, Inc.

Weight: 4.83% Shares: 3.21M Value: $61.91M

RXRX

RXRX

Recursion Pharmaceuticals, Inc.

Weight: 4.21% Shares: 11.88M Value: $54.04M

VCYT

VCYT

Veracyte, Inc.

Weight: 3.81% Shares: 1.07M Value: $48.95M

CDNA

CDNA

CareDx, Inc

Weight: 3.05% Shares: 2.08M Value: $39.10M

SDGR

SDGR

Schrödinger, Inc.

Weight: 3.03% Shares: 2.07M Value: $38.90M

ADPT

ADPT

Adaptive Biotechnologies Corporation

Weight: 2.64% Shares: 2.10M Value: $33.84M

NTLA

NTLA

Intellia Therapeutics, Inc.

Weight: 2.24% Shares: 2.95M Value: $28.74M

NRIX

NRIX

Nurix Therapeutics, Inc.

Weight: 2.11% Shares: 1.56M Value: $27.12M

WGS

WGS

GeneDx Holdings Corp.

Weight: 1.92% Shares: 181.11K Value: $24.60M

PACB

PACB

Pacific Biosciences of California, Inc.

Weight: 1.77% Shares: 10.91M Value: $22.70M

PRME

PRME

Prime Medicine, Inc.

Weight: 1.41% Shares: 4.87M Value: $18.03M

ARCT

ARCT

Arcturus Therapeutics Holdings Inc.

Weight: 1.32% Shares: 2.55M Value: $16.89M

CMPS

CMPS

COMPASS Pathways plc

Weight: 1.15% Shares: 2.10M Value: $14.78M

INCY

INCY

Incyte Corporation

Weight: 1.10% Shares: 132.91K Value: $14.18M

VRTX

VRTX

Vertex Pharmaceuticals Incorporated

Weight: 0.93% Shares: 25.36K Value: $11.88M